Hodgkin Disease
Showing 26 - 50 of 91
Hodgkin Disease Trial in Worldwide (Nivolumab, Doxorubicin, Vinblastine)
Active, not recruiting
- Hodgkin Disease
- Nivolumab
- +3 more
-
Los Angeles, California
- +37 more
Oct 25, 2021
Hodgkin Disease, Hodgkin Lymphoma Trial run by the NCI (procedure, drug, radiation)
Terminated
- Hodgkin Disease
- Hodgkin Lymphoma
- Auto stem cell transplant
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 16, 2021
Hodgkin Disease, Lymphoma, Non-hodgkin Trial in New York (Carfilzomib, TGR-1202)
Terminated
- Hodgkin Disease
- Lymphoma, Non-hodgkin
-
New York, New YorkColumbia University Irving Medical Center - Center for Lymphoid
Jun 28, 2021
Multiple Myeloma, Non-Hodgkin Lymphoma, Hodgkin Disease Trial in Taiwan (TG-0054 (2.24 mg/kg), TG-0054 (3.14 mg/kg))
Completed
- Multiple Myeloma
- +2 more
- TG-0054 (2.24 mg/kg)
- TG-0054 (3.14 mg/kg)
-
Chiayi, Taiwan
- +5 more
Apr 14, 2021
Multiple Myeloma, Non-Hodgkin Lymphoma, Hodgkin Disease Trial in Stony Brook, Nashville (TG-0054 combined with G-CSF)
Completed
- Multiple Myeloma
- +2 more
- TG-0054 combined with G-CSF
-
Stony Brook, New York
- +1 more
Apr 14, 2021
Long-Term Survivors of Hodgkin's and Non-Hodgkin's Lymphoma
Completed
- Hodgkin Disease
- Lymphoma, Non-Hodgkin
- Survey
-
Rochester, New YorkUniversity of Rochester Medical Center
Mar 4, 2021
Hodgkin Disease, Lymphoma, Large-Cell, Anaplastic Trial in China (Brentuximab Vedotin)
Completed
- Hodgkin Disease
- Lymphoma, Large-Cell, Anaplastic
- Brentuximab Vedotin
-
Beijing, Beijing, China
- +6 more
Feb 3, 2021
Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Hodgkin Disease Trial in Chicago, Saint Louis (Romidepsin,
Completed
- Lymphoma, T-Cell, Cutaneous
- +3 more
- Romidepsin
- +4 more
-
Chicago, Illinois
- +1 more
Nov 16, 2020
Occupational Status and Hematological Disease
Completed
- Chronic Myeloid Leukemia
- +4 more
- Study questionnaire
- SF-36 Questionnaire
-
Bari, Italy
- +4 more
Oct 5, 2020
Hodgkin Disease Trial (Lenalidomide (Revlimid®))
Completed
- Hodgkin Disease
- Lenalidomide (Revlimid®)
- (no location specified)
Sep 16, 2020
Hodgkin Disease, Non Hodgkin Lymphoma, Lymphoepithelioma Trial in Houston (LMP1/2 CTLs (ALCI - Group A), LMP1/2 CTLs (ALCI -
Completed
- Hodgkin Disease
- +3 more
- LMP1/2 CTLs (ALCI - Group A)
- +8 more
-
Houston, Texas
- +1 more
May 26, 2020
Classical Hodgkin Lymphoma, Hodgkin Lymphoma (Category), Hodgkin Disease Trial in Riyadh (Adriamycin, Cyclophosphamide,
Unknown status
- Classical Hodgkin Lymphoma
- +3 more
- Adriamycin
- +5 more
-
Riyadh, Saudi ArabiaKing Abdulaziz Medical City, Ministry of National Guard
Nov 14, 2019
Lymphoma, Hodgkin Disease, Lymphoma, Non-Hodgkin Trial in Turku (68Ga-DOTANOC PET/CT; Diffusion weighted MRI)
Completed
- Lymphoma
- +2 more
- 68Ga-DOTANOC PET/CT; Diffusion weighted MRI
-
Turku, FinlandTurku University Hospital
Jun 18, 2019
Hodgkin Disease Trial in United States (brentuximab vedotin, bendamustine)
Completed
- Hodgkin Disease
- brentuximab vedotin
- bendamustine
-
Birmingham, Alabama
- +12 more
Jan 24, 2019
Hodgkin Disease Trial in Houston (Filgrastim SD/01, Adriamycin, Bleomycin)
Completed
- Hodgkin Disease
- Filgrastim SD/01
- +4 more
-
Houston, TexasUT MD Anderson Cancer Center
Oct 30, 2018
Hodgkin Disease, Lymphoma, Non-Hodgkin, Tumors Trial (MK-8776, Gemcitabine)
Completed
- Hodgkin Disease
- +2 more
- (no location specified)
Jul 26, 2018
Lymphoma, Hodgkin Disease, Lymphoma, Hodgkin Disease Trial in Stanford, Vallejo (Vincristine, Cyclophosphamide, Doxorubicin)
Completed
- Lymphoma, Hodgkin Disease
- +3 more
- Vincristine
- +6 more
-
Stanford, California
- +1 more
Jun 25, 2018
Hodgkin Disease Trial in United Kingdom (Brentuximab Vedotin)
Completed
- Hodgkin Disease
- Brentuximab Vedotin
-
Birmingham, United Kingdom
- +11 more
May 9, 2018
Non Hodgkin's Lymphoma, Hodgkin Disease, Multiple Myeloma Trial in Boston (Fludarabine and total body irradiation, Total body
Terminated
- Non Hodgkin's Lymphoma
- +2 more
- Fludarabine and total body irradiation
- Total body irradiation
-
Boston, MassachusettsMassachusetts General Hospital
Mar 26, 2018
Hodgkin Disease, Lymphoma, Non-Hodgkin Trial in Saint Louis (Carmustine, Etoposide phosphate, Cytarabine)
Completed
- Hodgkin Disease
- Lymphoma, Non-Hodgkin
- Carmustine
- +3 more
-
Saint Louis, MissouriWashington University School of Medicine
Jan 16, 2018
Multiple Myeloma, Non-Hodgkin Lymphoma, Hodgkin Disease Trial in Minneapolis (Leuprolide, hematopoietic cell transplant, reduced
Terminated
- Multiple Myeloma
- +4 more
- Leuprolide
- +2 more
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Dec 3, 2017
Defining PET / CT Protocols With Optimized F18-FDG Dose,
Completed
- Malignant Neoplasm of Breast
- +7 more
- Image quantify
-
Salvador, Bahia, BrazilHospital Sao Rafael
Nov 27, 2017
Consent for Obtaining Additional Tissue at Time ofDiagnostic
Completed
- Lymphoma
- Hodgkin Disease
- tumor tissue aspiration
- phlebotomy
-
Stanford, CaliforniaStanford University School of Medicine
Nov 16, 2017